CENTER LABORATORIES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.95 TWD | -0.92% |
|
+2.26% | -3.05% |
| Apr. 22 | Center Laboratories, Inc. cancelled the transaction announced on June 20, 2023 | CI |
| Mar. 19 | Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Center Laboratories, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | +1.11% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 7 M€ | +0.11% | - | |
| 0.00% | 34 M€ | +2.14% | - |
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -3.05% | 903M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 4123 Stock
- Funds and ETFs Center Laboratories, Inc.
